Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease

MLA

Ari Zimran, et al. “Taliglucerase Alfa: Safety and Efficacy across 6 Clinical Studies in Adults and Children with Gaucher Disease.” Orphanet Journal of Rare Diseases, vol. 13, no. 1, Feb. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13023-018-0776-8.

APA

Ari Zimran, Michael Wajnrajch, Betina Hernandez, & Gregory M. Pastores. (2018). Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease. Orphanet Journal of Rare Diseases, 13(1), 1–10. https://doi.org/10.1186/s13023-018-0776-8

Chicago

Ari Zimran, Michael Wajnrajch, Betina Hernandez, and Gregory M. Pastores. 2018. “Taliglucerase Alfa: Safety and Efficacy across 6 Clinical Studies in Adults and Children with Gaucher Disease.” Orphanet Journal of Rare Diseases 13 (1): 1–10. doi:10.1186/s13023-018-0776-8.